A five-day course of ivermectin may reduce the duration of COVID-19 illness

A five-day course of ivermectin may reduce the duration of COVID-19 illness

Bibliographic Details
Main Authors:	Sabeena Ahmed, Wasif Ali Khan
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	International Journal of Infectious Diseases
Subjects:	COVID-19 ivermectin antiviral effect
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971221006068

Similar Items

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
by: Sabeena Ahmed, et al.
Published: (2021-02-01)

Role of ivermectin in COVID-19: Wishful thinking or scientific optimism
by: Prafull Mohan, et al.
Published: (2020-01-01)

COVID-19: Ivermectin; Molecular Mechanisms, Limitations, Suggestions
by: Mustafa KESMEN, et al.
Published: (2020-12-01)

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
by: Ahmad F. Eweas, et al.
Published: (2021-01-01)

Current therapeutic applications and pharmacokinetic modulations of ivermectin
by: Khan Sharun, et al.
Published: (2019-08-01)

Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
by: David A. Jans, et al.
Published: (2020-09-01)

Antiviral Activity of Ivermectin Against SARS-CoV-2: An Old-Fashioned Dog with a New Trick—A Literature Review
by: Mudatsir Mudatsir, et al.
Published: (2020-08-01)

Searching for ivermectin resistance in a Strongylidae population of horses stabled in Poland
by: A. Zak, et al.
Published: (2017-07-01)

Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
by: Dr. Ajay Kumar Shukla, et al.
Published: (2021-08-01)

Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
by: Carlos Chaccour, et al.
Published: (2017-04-01)

Efficacy of Ivermectin against Ascaris suum in Swine
by: P.B. Chavhan, et al.
Published: (2009-12-01)

Ivermectin and malaria control
by: Satoshi Ōmura, et al.
Published: (2017-04-01)

New developments in the treatment of rosacea – role of once-daily ivermectin cream
by: Cardwell LA, et al.
Published: (2016-03-01)

Use of ivermectin in the treatment of Covid-19: A pilot trial
by: Henrique Pott-Junior, et al.
Published: (2021-01-01)

14-Day Repeated Intraperitoneal Toxicity Test of Ivermectin Microemulsion Injection in Wistar Rats
by: Zhen Dong, et al.
Published: (2020-12-01)

Identification of the metabolites of ivermectin in humans
by: Phornpimon Tipthara, et al.
Published: (2021-02-01)

Ivermectin Inhibits Bovine Herpesvirus 1 DNA Polymerase Nuclear Import and Interferes With Viral Replication
by: Sohail Raza, et al.
Published: (2020-03-01)

Acute behavioural and physiological responses of sheep to S/C ivermectin injection
by: Usama T. Mahmoud, et al.
Published: (2019-03-01)

Treatment of childhood phthiriasis palpebrarum with systemic ivermectin
by: Ibrahim Fouda, MD, et al.
Published: (2021-08-01)

THERAPEUTIC MANAGEMENT OF SARCOPTIC MANGE IN RABBIT WITH IVERMECTIN
by: Joyjit Mitra, et al.
Published: (2014-06-01)

Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway
by: Carlos Chaccour, et al.
Published: (2017-04-01)

Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways
by: Carlos Chaccour, et al.
Published: (2017-04-01)

Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
by: R. Choudhary, et al.
Published: (2020-05-01)

Inhibition of Plasmodium sporogonic stages by ivermectin and other avermectins
by: Raquel Azevedo, et al.
Published: (2019-11-01)

Prolonged persistence of ivermectin from reindeer faeces on pastures
by: Kjetil Åsbakk
Published: (2007-04-01)

Efficiency of parenteral and oral ivermectin treatment on parasites in reindeer
by: T. Soveri, et al.
Published: (1990-09-01)

IVERMECTIN 3.15% FORMULATION-AN EFFICACY STUDY IN CATTLE
by: S. Mondal, et al.
Published: (2015-06-01)

Ivermectin treatment for Strongyloides infection in patients with COVID-19
by: Elizabeth Leung, et al.
Published: (2021-07-01)

Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19
by: Aref ZF, et al.
Published: (2021-06-01)

Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial
by: Shoaib Ashraf, et al.
Published: (2021-09-01)

Differences in protein expression associated with ivermectin resistance in Caenorhabditis elegans
by: Dauana Mesquita Sousa, et al.

Activation of Chloride Channels with the Anti-parasitic Agent Ivermectin Induces Membrane Hyperpolarization and Cell Death in Leukemia Cells
by: Sharmeen, Sumaiya
Published: (2010)

Activation of Chloride Channels with the Anti-parasitic Agent Ivermectin Induces Membrane Hyperpolarization and Cell Death in Leukemia Cells
by: Sharmeen, Sumaiya
Published: (2010)

Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
by: Nurullah Okumuş, et al.
Published: (2021-05-01)

Ação "in vitro" do Ivermectin sobre ovos de Lagochilascaris Minor leiper, 1909
by: Dulcinéia Maria Barbosa Campos, et al.
Published: (1988-08-01)

CDC Warns of Increased Ivermectin Overdoses
by: Richard A. Robbins, MD
Published: (2021-08-01)

Drug interactions of ivermectin with a focus on COVID-19 treatment
by: Padmaja Udaykumar, et al.
Published: (2021-01-01)

Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities
by: Zena Wehbe, et al.
Published: (2021-03-01)

Evaluation of the efficacy of ivermectin against Theileria orientalis infection in grazing cattle
by: Jinho Park, et al.
Published: (2019-08-01)

Ivermectin selection and characterization of the life history traits of Heligmosomoides polygyrus (Nematoda)
by: Njoroge, Joyce Muthoni
Published: (1995)